SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-19-000156
Filing Date
2019-08-08
Accepted
2019-08-08 16:12:53
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20190630.htm   iXBRL 10-Q 1666240
2 EX-10.1 exhibit101ligand-amend.htm EX-10.1 40766
3 EX-31.1 lgnd63019exhibit311.htm EX-31.1 20759
4 EX-31.2 lgnd63019exhibit312.htm EX-31.2 21089
5 EX-32.1 lgnd63019exhibit321.htm EX-32.1 15185
11 lgnd-20190630_g1.jpg GRAPHIC 11735
  Complete submission text file 0000886163-19-000156.txt   7624957

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20190630.xsd EX-101.SCH 40642
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20190630_cal.xml EX-101.CAL 106834
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20190630_def.xml EX-101.DEF 243270
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20190630_lab.xml EX-101.LAB 615777
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20190630_pre.xml EX-101.PRE 389399
12 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20190630_htm.xml XML 1438896
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 191009646
SIC: 2834 Pharmaceutical Preparations